Innovation Corner: Biofilm and Cleaning Technology
Innovation Corner: Biofilm and Cleaning Technology
Environmental Services management has evolved over the years in its definition of “clean,” which used to mean “looking” and “smelling” clean, then evolved to a more centralized focus on high-touch surfaces and “evaluating” clean either through ATP or fluorescent marking pens. Unfortunately, as our understanding of HAIs progresses, we need to update our definition of “clean” again to recognize the hidden enemy of biofilm.
According to the National institutes of Health (NIH), "Biofilms are responsible for approximately 80% of all human bacterial infections and are a primary driver of persistence in healthcare-associated infections (HAIs)." This is the new frontier of patient safety and we must rise to meet the challenge presented.
What Are Biofilms?
As opposed to “loose” bacteria residing on a surface (aka planktonic bacteria), biofilms are colonies that form on a surface and protect themselves with a coating known as Extracellular Polymeric Substance (EPS). This matrix acts like a suit of armor, protecting pathogens like C. diff, MRSA, and Pseudomonas from traditional disinfectants. These biofilms can be made of a single bacterial species or form what is called a multi-species biofilm or polymicrobial biofilm, which are even harder to penetrate, as each different species lends its own adaptive capabilities to the matrix.
Once formed, biofilms can persist on healthcare surfaces for months and can survive applications of disinfectants 100x more concentrated than what is approved to kill planktonic cells and can form as dry biofilms that reside on normal surfaces or wet biofilms in drains, sinks, and ice machines. Dry biofilms can even generate false negatives in surface testing, such as swabbing or ATP testing, since the EPS layer acts as a “cloaking device” that prevents swab collection and the bacteria internally enter a dormant state that produces so little ATP that meters will frequently pass areas impacted by biofilms.
The Tools of Detection & Destruction
A new suite of tools is coming to the market to help healthcare workers detect biofilms. Optotracers, Protein & Carbohydrate Binders, and specialized UV lamps are technologies that help field workers identify biofilms on surfaces either through binding to polysaccharides, sugars, and proteins and glowing under specific light spectrums via induced fluorescence or use specific wavelengths of light (such as 365nm UV) to cause autofluorescence – meaning the biofilm glows without the aid of a chemical spray. While the specifics of these technologies are outside the scope of this article, know that Xanitos is already using or piloting these technologies in the field.
In terms of cleaners and disinfectants, performance can vary. Some disinfectants, such as Hypochlorous Acid (HOCL) have an EPA biofilm kill claim, but they are specific to Staphylococcus aureus and Pseudomonas aeruginosa and not polymicrobial biofilms. While not identical, the similarity between the armor provided by a spore and the protection of a biofilm, most sporicidals have the ability to degrade biofilm matrixes, so oxidizing agents like AHP or Peracetic Acid perform well while some new studies show that sodium hypochlorite (bleach) may only be effective on Candidozyma auris in much higher concentrations than most formulations provide.
Additionally, while HOCL performs well on biofilm, it has some drawbacks. It is an ineffective surfactant, meaning a two-step process of cleaning/disinfection is required. On-site generators can provide ample amounts of HOCL for pennies per gallon, but there is some regulatory ambiguity as the generator may be EPA-registered, but the chemical that comes out of it is not. It is also chemically unstable, so the generated product has a short shelf-life. Ready-to-use HOCL is available in a stabilized format but is prohibitively expensive for widespread use.
Probiotic cleaners, as mentioned in one of my prior articles, were pioneered in Europe and use biology against itself by having beneficial bacterial colonies consume biofilm and out-compete bacteria to prevent re-colonization. These are extremely effective cleaners and functional disinfectants but not recognized by the EPA as a disinfectant since they are made of bacterial colonies themselves, necessitating a two-step process as well.
NaDCC tablets, such as Defender, PurTab, 3M C-Diff tablets, etc. generate HOCL on contact and most configurations come coupled with a detergent to make a one-step cleaner/disinfectant (while “pure” versions are made for use with electrostatic sprayers and foggers). These are compact tablets that are relatively easy to deploy, though they carry some handling risk and can generate some respiratory irritation in their concentrated form.
The Bottom Line
Biofilms pose a serious risk for patients, and established protocols may be ineffective at detecting or eliminating the risk. The issue is complex and evolving, and there is no one-size-fits-all solution on the market. It takes a service provider who understands the science, the tools, and the nuances of the problem to design a cleaning program that effectively rises to the challenge. That’s why Xanitos makes investments in research and technology to partner with healthcare systems and bring solutions to the table that work.
